Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

517
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
517
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of autonomic nervous system on relaxant action of bisphenol A in porcine myometrium.

Polish journal of veterinary sciences·2025
Same author

Montelukast potentiates the relaxing effect of nifedipine in the porcine myometrium.

Polish journal of veterinary sciences·2024
Same author

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.

The journal of prevention of Alzheimer's disease·2024
Same author

Effect of siltuximab, omalizumab, infliximab, pembrolizumab and vedolizumab on selected haematological and biochemical parameters in a pig model.

Polish journal of veterinary sciences·2020
Same author

Pharmacokinetics and pharmacodynamics of a single dose of sustained-release azithromycin formulation in pigeons.

Polish journal of veterinary sciences·2020
Same author

Hard water may increase the inhibitory effect of feed on the oral bioavailability of oxytetracycline in broiler chickens.

Polish journal of veterinary sciences·2019
Same journal

Comparative Biochemical and Functional Characterization of a Novel Human Fibrinogen Concentrate (BT524) and Established Plasma-Derived Fibrinogen Concentrates.

Drug research·2026
Same journal

Preclinical Assessment and Tissue Distribution of Vodobatinib, a Third Generation BCr-Abl 1 Inhibitor.

Drug research·2026
Same journal

Ellagic Acid Attenuates Doxorubicin-induced Cardiomyocyte Ferroptosis Via Nuclear Factor Erythroid 2-Related Factor 2 Signaling.

Drug research·2026
Same journal

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Drug research·2026
Same journal

Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats.

Drug research·2026
Same journal

Synergistic Effects of Curcumin and Temozolomide in Overcoming Glioblastoma Drug Resistance through Regulation of O6-Methylguanine-DNA Methyltransferase, Mismatch Repair, and Poly(Adenosine Diphosphate Ribose) Polymerase 1.

Drug research·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K

Sampling intervals verification in pharmacokinetics studies.

T Grabowski1, J J Jaroszewski2, M Sasinowska-Motyl3

  • 1Polpharma Biologics, Gdańsk, Poland.

Drug Research
|December 12, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to evaluate pharmacokinetic (PK) study quality by analyzing partial area under the curve (AUC) fields. Optimizing sampling intervals significantly improves the reliability of PK data, as shown with itraconazole.

More Related Videos

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.2K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.2K

Related Experiment Videos

Last Updated: May 4, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.2K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.2K

Area of Science:

  • Pharmacokinetics
  • Drug Development
  • Clinical Pharmacology

Background:

  • Regulatory agencies lack specific guidelines for planning sampling intervals in pharmacokinetic (PK) studies.
  • Sampling intervals directly influence the calculation of the area under the curve (AUC), a key PK parameter.
  • Optimizing sampling points is crucial for accurate PK assessment.

Purpose of the Study:

  • To propose a novel method for the qualitative evaluation of PK studies.
  • To assess the impact of sampling interval optimization on PK data reliability.
  • To establish an empirical method for PK study quality assessment based on AUC fractions.

Main Methods:

  • Analysis of partial AUC fields' values using average concentrations of itraconazole.
  • Comparison of PK data before (BO) and after (AO) sampling interval optimization.
  • PK calculations performed using Phoenix™ WinNonlin 6.3® and Biokinetica 4.0 software.
  • Development of an arithmetic formula and acceptance limit (AL%) for evaluating the mean of partial fields (MAF).

Main Results:

  • The coefficient of variation (CV%) for MAF decreased from 125.35% (BO) to 46.51% (AO).
  • AUC fractions exceeded the established AL% for BO data.
  • AUC fractions did not exceed the AL% for AO data, indicating improved quality.
  • The proposed empirical method demonstrated the effectiveness of optimized sampling intervals.

Conclusions:

  • Optimizing sampling intervals significantly enhances the quality and reliability of pharmacokinetic studies.
  • The proposed empirical method, based on AUC fraction analysis, provides a valuable tool for PK study quality assessment.
  • This method can be applied to improve the design and evaluation of future PK studies.